今天，A股三大指数午后集体回调。全市场成交额11826亿元，较上日增加429亿元。医药板块逆势走 强，CRO、减肥药、化学制药等方向领涨。 14:00左右， 多只沪深300ETF量能显著放大 。截至收盘，华泰柏瑞沪深300ETF成交额近34亿元，易方 达沪深300ETF、嘉实沪深300ETF成交额显著放量。 截至收盘，沪指跌0.94%，深证成指跌0.85%，创业板指跌1.18%。板块方面，可控核聚变、贵金属、创 新药、维生素等板块涨幅居前，港口、游戏、算力、电力等板块跌幅居前。 赛力斯全天成交额超100亿元 赛力斯涨停，全天成交额超100亿元。 关注" 新华网财经 "视频号 更多财经资讯等你来看 渤海证券称，长期来看，美国居高不下的债务和赤字率、潜在的再通胀风险、全球复杂的地缘局势以及 多国央行购金等因素均对金价形成支撑。当前宏观情绪缓和背景下需关注短期波动，而长期基本面利好 因素仍存，黄金具备战略配置价值。 知名黄金分析师Jordan Roy-Byrne认为，黄金价格在年底有可能达到3700美元/盎司。金价将在未来12个 月内达到4400美元至4500美元/盎司。此外，白银价格也将突破100美元/盎司。 （ ...

Group 1 - The A-share market experienced a collective pullback, with the Shanghai Composite Index closing down 0.94% at 3348.37 points, while 1107 stocks rose and 4204 stocks fell, highlighting the strong performance of controllable nuclear fusion concepts [1] - The 60th session of the stock simulation competition concluded with the champion achieving a return of 28.38%, the runner-up 27.28%, and the third place 26.60%, with 460 participants earning positive returns [1][2] - The upcoming 61st session of the competition will allow participants to register from May 24 to May 30, with the competition running from May 26 to May 30, featuring a simulated capital of 500,000 yuan [1][7] Group 2 - Key market trends included a focus on controllable nuclear fusion and the pet economy, with rapid shifts in market hotspots testing participants' trading skills [2][5] - Notable trades included the champion's successful investment in Zhongzhou Special Materials, buying at 23.45 yuan and selling at 33.24 yuan, yielding significant profits [4] - Participants also showed interest in high-dividend assets such as banks and utilities, which are seen as safer investments during market downturns [6] Group 3 - The competition's structure has changed to weekly contests, increasing the frequency of reward opportunities, with cash prizes for positive returns [7][8] - Participants can earn additional benefits such as access to expert holdings and market insights through the competition [9] - The competition encourages active participation, with a point system rewarding consistent trading activity [8][12]

Market Overview - On May 23, A-shares experienced a collective pullback, with the Shanghai Composite Index down 0.94% closing at 3348.37 points, the Shenzhen Component down 0.85% at 10132.41 points, and the ChiNext Index down 1.18% at 2021.50 points [1] - The trading volume in the Shanghai and Shenzhen markets reached 115.56 billion, an increase of 52.9 billion compared to the previous day [1] - The market saw more stocks decline than rise, with over 1100 stocks increasing and more than 50 hitting the daily limit up [1] Sector Performance - Precious metals, chemical pharmaceuticals, and medical services sectors showed the highest gains, while shipping ports, gaming, trade, internet services, and diversified finance sectors faced the largest declines [1] - The market's cautious sentiment was reflected in the trading patterns, with significant fluctuations observed in micro-cap stocks and the North Exchange [3][5] Notable Stocks - Wangzi New Materials saw a significant price increase of nearly 60% since May 15, driven by developments in controllable nuclear fusion projects [7] - The stock experienced high volatility, with daily trading ranges exceeding 20% on May 21 and 16.01% on May 23, indicating strong market speculation and liquidity risks [7] - Heng Rui Pharmaceutical's H-shares debuted on the Hong Kong Stock Exchange, surging approximately 37% at one point, with a market capitalization exceeding 380 billion HKD [9][11] Investment Sentiment - Analysts remain cautiously optimistic about the market's future, suggesting a continuation of index fluctuations and sector rotations [9] - The pharmaceutical sector is expected to regain stability and growth, supported by ongoing innovations and favorable policies [12] - The biotechnology ETF saw an increase of over 1%, reflecting positive sentiment in the biopharmaceutical industry [12]

至收盘时，上证指数报3348.37点，跌幅0.94%，成交额约4686亿元；深证成指报10132.41点，跌幅 0.85%，成交额约6870亿元；创业板指报2021.50点，跌幅1.18%，成交额约3129亿元；北证50指数报 1370.04点，跌幅1.35%，成交额约272亿元。 热点板块 盘面上，贵金属、医药商业、化学制药、可控核聚变、CRO、超导等板块和概念股涨幅居前；港口航 运、游戏、零售、共享单车、算力租赁、云办公等板块和概念股跌幅居前。 机构观点 巨丰投顾：周五市场震荡运行，医疗服务板块涨幅居前。当前，宽松的货币政策以及中长期资金流入资 本市场预期依然较强。在政策刺激下，A股与经济有望同步出现向上的拐点，市场将震荡上行。具体投 资方向上，中线建议关注维持高景气度的半导体、消费电子、人工智能、机器人、低空经济等领域的增 量机会。 国泰海通证券：2024年以来黄金珠宝行业进入了出清与升级并行阶段，龙头企业逐步由开店策略走向单 店提效，品牌方与加盟商形成推广高毛利率产品的"合力"；差异化产品推动黄金珠宝公司由"渠道品 牌"走向"消费品品牌"，全年看黄金珠宝行业的估值提升逻辑仍将持续演绎，看好产品力突出& ...

Market Overview - The market experienced a high-to-low trading session, with the ChiNext Index leading the decline, dropping by 1.18% [1] - The total trading volume for the Shanghai and Shenzhen markets reached 1.16 trillion, an increase of 52.9 billion compared to the previous trading day [1] Sector Performance - The controlled nuclear fusion concept stocks surged again, with Haohan Huaton hitting the daily limit [1] - Innovative drug concept stocks showed strong fluctuations, with Zhongsheng Pharmaceutical also hitting the daily limit [1] - In contrast, the port and shipping stocks underwent adjustments, with Nanjing Port hitting the daily limit down [1] - Power stocks experienced a downward trend, with Hunan Development hitting the daily limit down [1] Index Performance - The Shanghai Composite Index closed down by 0.94% at 3348.37 [2] - The Shenzhen Component Index fell by 0.85% to 10132.41 [2] - The ChiNext Index decreased by 1.18%, closing at 2021.50 [2] Additional Metrics - The limit-up rate was recorded at 62.00% with 41 stocks hitting the limit [5] - The opening rate was 70%, and the profit rate was 45% [5]

A股三大指数午后集体跳水，截至收盘，沪指跌0.94%，深成指跌0.85%，创业板指跌1.18%，北证50指 数跌1.35%。全市场成交额11826亿元，较上日放量429亿元。全市场4000只个股下跌。 板块题材上，可控核聚变、创新药、贵金属板块领涨；兵装重组、港口航运板块跌幅居前。 盘面上，可控核聚变概念涨幅居前，王子新材（002735）、哈焊华通（301137）、雪人股份 （002639）、融发核电（002366）涨停。医药股持续活跃，海辰药业（300584）、众生药业 （002317）、先达股份（603086）、塞力医疗（603716）涨停。机器人概念股反弹，赛力斯 （601127）、沃特股份（002886）涨停，东土科技（300353）涨超10%，港口航运概念领跌，南京港 （002040）、连云港跌停，宁波海运（600798）跌超5%；电力概念跌幅居前，湖南发展（000722）、 西昌电力（600505）跌停。 暗盘资金流向曝光！提前捕捉庄家建仓信号>> 热点概览： 涨停天梯榜： 【5连板】 滨海能源（000695）。 【3连板】 永安药业（002365）、汇得科技（603192）。 【2连板】 烽火电 ...

各位朋友中午好！这里是帮主郑重的午评时间。今儿这盘面有点"温水煮青蛙"的意思，三大指数晃悠着往上爬，创业板指算是相对精神点儿，半日涨了 0.48%，沪指跟深成指就显得有点磨磨蹭蹭，分别涨了0.08%和0.50%，倒是北证50指数挺带劲儿，涨了1.57%，看来小盘股今儿有点活跃。 再看看跌得惨的板块，港口航运和电力算是今儿的"难兄难弟"。南京港直接跌停，连云港、宁波海运跌超5%，港口股最近受运价波动和外围消息影响， 有点抬不起头；电力板块里，乐山电力、湖南发展、西昌电力跌超5%，可能跟近期煤炭价格波动和夏季用电预期提前兑现有关，中长线来看这些板块有 周期性，跌下来或许是蹲坑的机会，但得耐得住性子。 跟大家扯两句题外话啊，现在这市场就像打太极，涨得不急不躁，跌得也不慌不忙，特别考验咱们中长线投资者的心态。手里有底仓的朋友，遇到这种 震荡行情可以稍微动点小脑筋，比如盯着强势板块里的核心标的，别轻易被日内波动晃下车。像医药股这种突然走强的板块，要是你之前有布局，今儿 冲高可以减点仓落袋，但底仓得留好，说不定后面还有戏；要是没赶上的也别着急追，等回调的时候再找机会更稳妥。 最后提醒一句，现在量能没放出来，市场还在磨底阶 ...

Group 1 - The controllable nuclear fusion sector in A-shares experienced a significant surge, with the sector index rising over 4% and 30 stocks within the sector increasing in value [1][2] - Notable performers included Xue Ren Co., Ltd. (002639) and Rongfa Nuclear Power (002366), both hitting the daily limit up, while Chen Guang Medical (430300) saw an increase of over 26% [1][2] - The controllable nuclear fusion index reached 1476.66, reflecting a rise of 3.71% [2] Group 2 - The U.S. nuclear energy sector saw a collective surge in stock prices, which positively influenced Asian nuclear power stocks, leading to gains in the Hong Kong market [3][4] - The China General Nuclear Power Index (887716.WI) rose by 3.6%, while the Nuclear Power Index (884046.WI) increased by 2.32% [3][4] Group 3 - Recent developments in the nuclear energy sector indicate a critical phase in the construction of nuclear fusion experimental reactors, with significant progress expected [5] - The BEST reactor project has officially commenced assembly, aiming for completion by 2027, while the CRAFT reactor is projected to be completed by the end of 2025 [5] - The market anticipates a rapid development in the controllable nuclear fusion industry, with increased project tenders and commercialization efforts expected in 2025 [5]

Market Overview - The A-share market showed slight gains with the Shanghai Composite Index up by 0.08% to 3382.96 points, while the Shenzhen Component increased by 0.5% and the ChiNext Index rose by 0.48% [1][2] - The total trading volume for A-shares reached 661.11 billion yuan during the half-day session [1] Monetary Policy - The People's Bank of China conducted a reverse repurchase operation of 142.5 billion yuan for 7-day terms at a fixed rate of 1.4%, with a net injection of 36 billion yuan for the day after considering maturing reverse repos [2] E-commerce and Digital Consumption - In the first four months of the year, China's e-commerce sector has enhanced the integration of domestic and foreign trade, with online sales of digital products increasing by 8.4%. Notably, sales of smart robots and smart home systems surged by 87.6% and 16%, respectively [3] Company Developments - China Petroleum & Chemical Corporation (Sinopec) announced its investment in Contemporary Amperex Technology Co., Ltd. (CATL) as a cornerstone investor, which is part of a broader strategy to enhance infrastructure for battery swapping stations [3] - Zhongzhou Special Materials is experiencing strong demand due to increased capital expenditure in the oil and gas sector, with expansion into new energy and nuclear power applications [8] - Aike Cyber is focusing on semiconductor power supply technologies, achieving competitive performance metrics compared to leading international brands [8] - Guoguang Electric is expanding into the civil market for pressure vessel measurement and control components, driven by technological innovation and domestic substitution trends [8] - Xuguang Electronics is making strides in high-end technology sectors, achieving breakthroughs in critical technologies and domestic replacements [8] Sector Performance - The healthcare sector saw significant gains, with companies like Yong'an Pharmaceutical and Beirui Gene experiencing rapid stock price increases [3] - The controlled nuclear fusion sector led the market with an average increase of 3.35%, while shipping concepts lagged with a decline of 1.02% [4]

Market Overview - A-shares experienced slight fluctuations with major indices showing minor gains, including the Shanghai Composite Index rising for the fourth consecutive day [1] - The trading volume continues to shrink, indicating a potential decrease in market activity [1] Key Indices Performance - Shanghai Composite Index: 3,382.96 (+0.08%) - Shenzhen Component Index: 10,271.21 (+0.50%) - ChiNext Index: 2,055.44 (+0.48%) - Shanghai 50 Index: 2,738.01 (+0.16%) - CSI 300 Index: 3,925.58 (+0.30%) - STAR 50 Index: 993.56 (+0.29%) - North Exchange 50 Index: 1,410.71 (+1.58%) - CSI 1000 Index: 6,079.58 (+0.22%) [2] Pharmaceutical Sector - The pharmaceutical sector showed strong performance with significant gains in various sub-sectors, including AI healthcare and weight loss drugs, with some stocks reaching their daily limit [3] - Hengrui Medicine's H-shares debuted on the Hong Kong Stock Exchange, surging over 37% during trading, raising approximately HKD 9.9 billion, marking the largest IPO in the Hong Kong pharmaceutical sector in five years [5] Innovation in Pharmaceuticals - China's pharmaceutical industry is rapidly developing, with exports reaching USD 26.632 billion in Q1 2025, a 4.39% increase year-on-year, while imports decreased by 4.42% to USD 20.456 billion [7] - The number of active innovative drugs developed by Chinese companies reached 3,575 by the end of 2024, ranking first globally, with domestic products accounting for 42% of approved innovative drugs [7] Automotive Industry - The automotive supply chain was active, with various segments such as passenger cars and automotive components showing strong gains [8] - The passenger car market saw sales of 6.872 million units from January to April, a 7.9% increase year-on-year, while the new energy vehicle market experienced a 35.7% increase with sales of 3.324 million units [10] Solid-State Battery Developments - The solid-state battery sector received positive news, with the China Automotive Engineering Society releasing standards for solid-state batteries, facilitating technological upgrades [11] - Companies like Funeng Technology and Guoxuan High-Tech are making significant advancements in solid-state battery development, with plans for commercial delivery of products by the end of 2025 [11]